A woman was arrested last week after walking into the Bristol police station and firing multiple rounds.
The Office of the Inspector General has released videos that show a woman shooting inside of the Bristol police station lobby last week.In the video, Laprise walks up to the front lobby desk office windows and bangs on them with a gun. The front lobby desk was not occupied at the time.
Laprise was taken to Bristol Hospital for an evaluation. She was later released and returned to Bristol Police Department. She appeared in court on Friday morning for charges including criminal attempt to commit murder with special circumstances, carrying a firearm under the influence, unlawful discharge of a firearm, criminal use of a firearm, possession of a high capacity magazine, criminal mischief and breach of peace. She is due back in court on October 17.
Both the woman and Laprise agreed that Laprise should go home before Laprise drove off in the direction of the police station, the court documents said.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Connecticut residents seeing more stink bugs indoors as weather gets colderThere are ways to keep stink bugs outside. Just be careful about squishing them.
Read more »
Connecticut police search for truck passenger who allegedly threatened children with poisonThe Granby Police Department is actively seeking a truck passenger who allegedly approached a group of children in a threatening manner.
Read more »
10 scenic Fall foliage drives and hikes in ConnecticutAs the trees shed their green hues and don their fiery reds, oranges, and yellows, there’s a unique joy in embarking on scenic drives and hikes during the…
Read more »
Bristol-Myers Squibb to acquire Mirati in a $4.8 billion dealBristol-Myers Squibb to acquire Mirati in a $4.8 billion deal
Read more »
Bristol Myers Squibb to Acquire Mirati Therapeutics in Deal Worth Up to $5.8 BillionDeal expands pharmaceutical company’s portfolio of cancer drugs
Read more »